REGULATION OF HSV GENE EXPRESSION BY HCF

HCF 对 HSV 基因表达的调节

基本信息

  • 批准号:
    6520215
  • 负责人:
  • 金额:
    $ 27.09万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2001
  • 资助国家:
    美国
  • 起止时间:
    2001-03-01 至 2006-02-28
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (taken from Investigator's abstract):Productive infection by herpes simplex virus (HSV) is stimulated by the virally-encoded transcription factor VP16, which associates with the cellular transcription factor HCF-1 to form a multiprotein-DNA complex on each of the five viral immediate-early (IE) gene promoters. Failure of HSV to express sufficient levels of IE gene products may lead to the establishment of a latent infection in appropriate cell types such as sensory neurons. The importance of HCF-1 to the viral productive cycle is most clearly demonstrated by infection of cells with a conditionally inactivated version of HCF-1. This results in a significant delay in viral gene expression and severely reduced virus yield. Dr. Wilson proposes that differences in the activity or localization of HCF-1 in sensory neurons contribute to the establishment or maintenance of viral latency. In these cells, HCF-1 is found predominantly in cytoplasm, a striking contrast to most other cell types where HCF-1 is predominantly nuclear. Signals that promote reactivation also trigger a rapid relocalization of HCF-1 to the nucleus. To this end, they have identified a novel HCF-1 associated protein with characteristics of a nucleocytoplasmic shuttle factor that may be responsible for the dynamic localization of HCF-1 in neurons. Regulation of HCF-1 localization may also be important in other contexts. HCF-1 is required for transcriptional activation by a number of DNA-binding proteins and loss of HCF-1 leads to an arrest in G1 phase of the cell cycle. The aims of this proposal are to: (Aim 1) understand how VP16 and the novel shuttle protein (designated HPIP) selectively target HCF-1 rather than the close-relative HCF-2; (Aim 2) demonstrate suppression of IE gene expression by the candidate shuttle proteins (HPIP) and establish its mode of action in sensory neurons and other cell types; and (Aim 3) test the hypothesis that HCF-1 stimulates IE gene activation by interacting with additional transcription factors bound to sites flanking the VP16-responsive elements in each IE promoter. The investigator suggests that the pivotal role of HCF-1 in initiating viral IE gene expression represents an important target for the design of new therapeutic strategies to combat human diseases that arise from HSV infection.
描述(摘自研究者摘要):疱疹引起的生产性感染 单纯病毒(HSV)由病毒编码的转录因子刺激 VP 16,它与细胞转录因子HCF-1结合形成 5种病毒即早(IE)基因中每一种上的多蛋白-DNA复合物 发起人。HSV不能表达足够水平的IE基因产物可能 导致在适当的细胞类型中建立潜伏感染, 作为感觉神经元。HCF-1对病毒生产周期的重要性是 最清楚地证明了感染细胞的条件 HCF-1的失活版本。这导致了病毒基因的显著延迟, 表达并严重降低病毒产量。威尔逊博士建议, 感觉神经元中HCF-1活性或定位的差异 有助于建立或维持病毒潜伏期。在这些 HCF-1主要存在于细胞质中,与大多数细胞形成鲜明对比。 HCF-1主要是核的其他细胞类型。促进的信号 再活化也触发HCF-1快速重新定位到细胞核。到 为此,他们鉴定了一种新的HCF-1相关蛋白, 核质穿梭因子的特性, 用于HCF-1在神经元中的动态定位。HCF-1的调节 本地化在其它环境中也可能是重要的。需要HCF-1 转录激活的DNA结合蛋白和损失的数量 HCF-1导致细胞周期停滞在G1期。其目的是 目的1:了解VP 16和新型穿梭蛋白如何在细胞内表达, (指定为HPIP)选择性靶向HCF-1,而不是近亲 HCF-2;(目的2)证明候选物抑制IE基因表达 穿梭蛋白(HPIP),并建立其在感觉神经元中的作用模式, 目的3:验证HCF-1刺激IE基因的假说 通过与结合位点的额外转录因子相互作用激活 位于每个IE启动子中的VP 16应答元件的侧翼。研究者 提示HCF-1在启动病毒IE基因表达中的关键作用 代表了设计新治疗策略的重要目标, 对抗由HSV感染引起的人类疾病。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

ANGUS WILSON其他文献

ANGUS WILSON的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('ANGUS WILSON', 18)}}的其他基金

Viral disruption of host transcriptome integrity
病毒破坏宿主转录组完整性
  • 批准号:
    10666992
  • 财政年份:
    2023
  • 资助金额:
    $ 27.09万
  • 项目类别:
Viral disruption of host transcriptome integrity
病毒破坏宿主转录组完整性
  • 批准号:
    10641602
  • 财政年份:
    2022
  • 资助金额:
    $ 27.09万
  • 项目类别:
Regulation of HSV Gene Expression by HCF
HCF 对 HSV 基因表达的调节
  • 批准号:
    7097516
  • 财政年份:
    2001
  • 资助金额:
    $ 27.09万
  • 项目类别:
REGULATION OF HSV GENE EXPRESSION BY HCF
HCF 对 HSV 基因表达的调控
  • 批准号:
    6636431
  • 财政年份:
    2001
  • 资助金额:
    $ 27.09万
  • 项目类别:
REGULATION OF HSV GENE EXPRESSION BY HCF
HCF 对 HSV 基因表达的调控
  • 批准号:
    6707519
  • 财政年份:
    2001
  • 资助金额:
    $ 27.09万
  • 项目类别:
REGULATION OF HSV GENE EXPRESSION BY HCF
HCF 对 HSV 基因表达的调节
  • 批准号:
    6283496
  • 财政年份:
    2001
  • 资助金额:
    $ 27.09万
  • 项目类别:
Regulation of HSV Gene Expression by HCF
HCF 对 HSV 基因表达的调节
  • 批准号:
    7201649
  • 财政年份:
    2001
  • 资助金额:
    $ 27.09万
  • 项目类别:
REGULATION OF HSV GENE EXPRESSION BY HCF
HCF 对 HSV 基因表达的调控
  • 批准号:
    6852659
  • 财政年份:
    2001
  • 资助金额:
    $ 27.09万
  • 项目类别:
Regulation of HSV Gene Expression by HCF
HCF 对 HSV 基因表达的调节
  • 批准号:
    7595040
  • 财政年份:
    2001
  • 资助金额:
    $ 27.09万
  • 项目类别:

相似海外基金

Non-canonical chimeric proteins generated during Adenovirus infection
腺病毒感染期间产生的非典型嵌合蛋白
  • 批准号:
    10448505
  • 财政年份:
    2021
  • 资助金额:
    $ 27.09万
  • 项目类别:
Non-canonical chimeric proteins generated during Adenovirus infection
腺病毒感染期间产生的非典型嵌合蛋白
  • 批准号:
    10312411
  • 财政年份:
    2021
  • 资助金额:
    $ 27.09万
  • 项目类别:
Increasing efficiency in formation of chimeric proteins
提高嵌合蛋白形成的效率
  • 批准号:
    561998-2021
  • 财政年份:
    2021
  • 资助金额:
    $ 27.09万
  • 项目类别:
    University Undergraduate Student Research Awards
Decoration and Dimerization of Chimeric Proteins Mediated by Coiled-Coil Interactions
卷曲螺旋相互作用介导的嵌合蛋白的修饰和二聚化
  • 批准号:
    537306-2018
  • 财政年份:
    2019
  • 资助金额:
    $ 27.09万
  • 项目类别:
    Collaborative Research and Development Grants
Exploring the therapeutic potential of chimeric proteins
探索嵌合蛋白的治疗潜力
  • 批准号:
    1947736
  • 财政年份:
    2017
  • 资助金额:
    $ 27.09万
  • 项目类别:
    Studentship
TARGETING PROTEIN INTERACTIONS AND DESIGNING CHIMERIC PROTEINS
靶向蛋白质相互作用并设计嵌合蛋白质
  • 批准号:
    8364271
  • 财政年份:
    2011
  • 资助金额:
    $ 27.09万
  • 项目类别:
Therapeutic peanut allergen Fc gamma chimeric proteins to treat peanut allergy
用于治疗花生过敏的治疗性花生过敏原 Fc γ 嵌合蛋白
  • 批准号:
    8444422
  • 财政年份:
    2010
  • 资助金额:
    $ 27.09万
  • 项目类别:
Cat allergen-human Fc-gamma1 chimeric proteins to treat cat allergy
猫过敏原-人Fc-gamma1嵌合蛋白治疗猫过敏
  • 批准号:
    7907314
  • 财政年份:
    2010
  • 资助金额:
    $ 27.09万
  • 项目类别:
TARGETING PROTEIN INTERACTIONS AND DESIGNING CHIMERIC PROTEINS
靶向蛋白质相互作用并设计嵌合蛋白质
  • 批准号:
    8171849
  • 财政年份:
    2010
  • 资助金额:
    $ 27.09万
  • 项目类别:
Therapeutic peanut allergen Fc gamma chimeric proteins to treat peanut allergy
用于治疗花生过敏的治疗性花生过敏原 Fc γ 嵌合蛋白
  • 批准号:
    8313432
  • 财政年份:
    2010
  • 资助金额:
    $ 27.09万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了